10 results
COVID-19 Diagnosis and Management Summary
Clinical and laboratory testing
Lung Ultrasound
HRCT scan
In-hospital treatment
Severity assessment and respiratory support 
Post-mortem
COVID-19 Diagnosis ... and Management ... Summary Clinical ... Ultrasound HRCT ... #Summary #treatment
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess - Diagnosis ... Summary Lung ... pain, hemoptysis, dyspnea ... Abscess Management ... #Abscess #pulmonary
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
as data on new treatment ... US and updated treatment ... illness) • 20-40% dyspnea ... Cheatsheet #Diagnosis #Management ... #Summary #SARSCoV2
Hepatopulmonary Syndrome - Diagnosis and Management Summary
A defect in arterial oxygenation due to a gas exchange
Summary A defect ... absence of intrinsic lung ... Presentation: • Dyspnea ... • Platypnea - Dyspnea ... on radioactive lung
Shock - Diagnosis and Management Summary
 • Hypotension: SBP<90, SBP drop >40, MAP<65 (Normotension, HTN possible
Diagnosis and Management ... Summary • Hypotension ... Setup - Ultrasound ... Tamponade - Pulmonary ... #treatment #workup
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
abscess Primary ... hemoptysis • Dyspnea ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
abscess Primary ... hemoptysis • Dyspnea ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Endocarditis Summary

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV substance use
• IV catheter
• Recent
Endocarditis Summary ... verrucous) • Lung ... Heart Failure • Dyspnea ... Cerebral > Splenic, pulmonary ... Endocarditis #diagnosis #management
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
Toxicity Summary ... starting amiodarone treatment ... Dyspnea 3. ... macrophages Treatment ... #diagnosis #management
Langerhans Cell Histiocytosis (LCH)

Granulomatous Lesions comprising langerin-positive histiocytes and an inflammatory infiltrate can arise in virtually
Pulmonary Symptoms ... : Cough, dyspnea ... TREATMENT OPTIONS ... is crucial in pulmonary ... Histiocytosis #Diagnosis #Management